Herpetetrone nanosuspensions enhance drug solubility and bioavailability to improve anti-hepatic fibrosis effects

References

• Alshweiat, A., et al., 2018. Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation. European journal of pharmaceutical sciences, 122, 94–104. doi: 10.1016/j.ejps.2018.06.010.
   PubMed Web of Science ®Google Scholar
• Arora, D., et al., 2018. Recent advances in nanosuspension technology for drug delivery. Current pharmaceutical design, 24 (21), 2403–2415. doi: 10.2174/1381612824666180522100251.
   PubMed Web of Science ®Google Scholar
• Augustine, R., et al., 2018. Nanoparticle-in-microparticle oral drug delivery system of a clinically relevant darunavir/ritonavir antiretroviral combination. Acta biomaterialia, 74, 344–359. doi: 10.1016/j.actbio.2018.04.045.
   PubMed Web of Science ®Google Scholar
• Camargos, C. and Rezende, C.A., 2021. Antisolvent versus ultrasonication: bottom-up and top-down approaches to produce lignin nanoparticles (LNPs) with tailored properties. International journal of biological macromolecules, 193 (Pt A), 647–660. doi: 10.1016/j.ijbiomac.2021.10.094.
   PubMedGoogle Scholar
• Chinese Pharmacopoeia Committee, 1995. Drug standard of Ministry of Public Health of People’s Republic of China, Tibetan Medicine. Beijing: Chemical Industry Press, 133.
   Google Scholar
• Dienstag, J.L., et al., 2003. Histological outcome during long-term lamivudine therapy. Gastroenterology, 124 (1), 105–117. doi: 10.1053/gast.2003.50013.
   PubMed Web of Science ®Google Scholar
• Dong, Z., et al., 2022. Preparation of naringenin nanosuspension and its antitussive and expectorant effects. Molecules, 27 (3), 741. doi: 10.3390/molecules27030741.
   PubMed Web of Science ®Google Scholar
• Feng, X., et al., 2018. Hepatoprotective effect of Herpetospermum caudigerum Wall. on carbon tetrachloride-induced hepatic fibrosis in rats. Journal of cellular and molecular medicine, 22 (7), 3691–3697. doi: 10.1111/jcmm.13568.
   PubMed Web of Science ®Google Scholar
• Fu, Q., et al., 2013. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies. Colloids and surfaces. B, biointerfaces, 109, 161–166. doi: 10.1016/j.colsurfb.2013.01.066.
   PubMed Web of Science ®Google Scholar
• Han, Y., et al., 2006. Experimental research on in vitro inhibitory effect of Ganneng Dripping Pill on HBV. Chinese journal of experimental traditional medical formulae, 12, 169–171.
   Google Scholar
• Hang, L., et al., 2022. Insight into the in vivo fate of intravenous herpetrione nanosuspensions by aggregation-caused quenching probes. Chinese chemical letters, 33 (11), 4948–4951. doi: 10.1016/j.cclet.2022.03.108.
   Web of Science ®Google Scholar
• Hernandez-Gea, V. and Friedman, S.L., 2011. Pathogenesis of liver fibrosis. Annual review of pathology: mechanisms of disease, 6 (1), 425–456. [Database] doi: 10.1146/annurev-pathol-011110-130246.
   PubMedGoogle Scholar
• Huang, Z., Staufenbiel, S., and Bodmeier, R., 2022. Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs. Pharmaceutical research, 39 (5), 949–961. doi: 10.1007/s11095-022-03243-9.
   PubMed Web of Science ®Google Scholar
• Jacob, S., Nair, A.B., and Shah, J., 2020. Emerging role of nanosuspensions in drug delivery systems. Biomaterials research, 24 (1), 3. doi: 10.1186/s40824-020-0184-8.
   PubMedGoogle Scholar
• Jin, S.Y., et al., 2016. Lignans-rich extract from Herpetospermum caudigerum alleviate physical fatigue in mice. Chinese journal of integrative medicine, 22 (11), 840–845. doi: 10.1007/s11655-016-2254-2.
   PubMed Web of Science ®Google Scholar
• Kisseleva, T. and Brenner, D., 2021. Molecular and cellular mechanisms of liver fibrosis and its regression. Nature reviews. Gastroenterology & hepatology, 18 (3), 151–166. doi: 10.1038/s41575-020-00372-7.
   PubMed Web of Science ®Google Scholar
• Li, L., Yuan, H.L., and Wu, Q., 2006. Clinical study on effect of Ganneng Dripping Pill in treating chronic hepatitis B. Chinese journal of integrative medicine, 26, 788–790.
   Google Scholar
• Li, Q., et al., 2022. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7–NLRP3 interaction. EMBO reports, 23 (2), e53499.
   PubMed Web of Science ®Google Scholar
• Li, W.Q., et al., 2022. Traditional Chinese medicine: an important source for discovering candidate agents against hepatic fibrosis. Frontiers in pharmacology, 13, 962525. doi: 10.3389/fphar.2022.962525.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2015. Preparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenization. International journal of pharmaceutics, 490 (1–2), 324–333. doi: 10.1016/j.ijpharm.2015.05.070.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al., 2015. Synthesis and properties of single domain sphere-shaped barium hexa-ferrite nano powders via an ultrasonic-assisted co-precipitation route. Ultrasonics sonochemistry, 23, 46–52. doi: 10.1016/j.ultsonch.2014.08.001.
   PubMed Web of Science ®Google Scholar
• Liu, T., et al., 2015. Effect of drug physico-chemical properties on the efficiency of top-down process and characterization of nanosuspension. Expert opinion on drug delivery, 12 (11), 1741–1754. doi: 10.1517/17425247.2015.1057566.
   PubMed Web of Science ®Google Scholar
• Lu, Y., et al., 2015. Developing nanocrystals for cancer treatment. Nanomedicine, 10 (16), 2537–2552. doi: 10.2217/nnm.15.73.
   PubMed Web of Science ®Google Scholar
• Ma, Y., et al., 2020. A comparison of spray-drying and freeze-drying for the production of stable silybin nanosuspensions. Journal of nanoscience and nanotechnology, 20 (6), 3598–3603. doi: 10.1166/jnn.2020.17407.
   PubMed Web of Science ®Google Scholar
• Marzan, A.L., et al., 2018. Preparation and characterization of stable nanosuspension for dissolution rate enhancement of furosemide: a quality by design (QbD) approach. Current drug delivery, 15 (5), 672–685. doi: 10.2174/1567201815666180123094320.
   PubMed Web of Science ®Google Scholar
• Modarres-Gheisari, S., et al., 2019. Ultrasonic nano-emulsification—a review. Ultrasonics sonochemistry, 52, 88–105. doi: 10.1016/j.ultsonch.2018.11.005.
   PubMed Web of Science ®Google Scholar
• Pardhi, V., et al., 2018. Nanocrystals: an overview of fabrication, characterization and therapeutic applications in drug delivery. Current pharmaceutical design, 24 (43), 5129–5146. doi: 10.2174/1381612825666190215121148.
   PubMed Web of Science ®Google Scholar
• Parola, M. and Pinzani, M., 2019. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Molecular aspects of medicine, 65, 37–55. doi: 10.1016/j.mam.2018.09.002.
   PubMed Web of Science ®Google Scholar
• Schiff, E., et al., 2008. Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis. American journal of gastroenterology, 103 (11), 2776–2783. doi: 10.1111/j.1572-0241.2008.02086.x.
   PubMed Web of Science ®Google Scholar
• Shen, B., et al., 2016. Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation. Drug development and industrial pharmacy, 42 (11), 1772–1781. doi: 10.3109/03639045.2016.1173051.
   PubMed Web of Science ®Google Scholar
• Shen, B.D., et al., 2015. Hepatoprotective effects of lignans extract from Herpetospermum caudigerum against CCl4-induced acute liver injury in mice. Journal of ethnopharmacology, 164, 46–52. doi: 10.1016/j.jep.2015.01.044.
   PubMed Web of Science ®Google Scholar
• Shen, C.Y., et al., 2017. Self-discriminating fluorescent hybrid nanocrystals: efficient and accurate tracking of translocation via oral delivery. Nanoscale, 10 (1), 436–450. doi: 10.1039/c7nr06052a.
   PubMed Web of Science ®Google Scholar
• Shete, G., et al., 2015. Oral bioavailability and pharmacodynamic activity of hesperetin nanocrystals generated using a novel bottom-up technology. Molecular pharmaceutics, 12 (4), 1158–1170. doi: 10.1021/mp5008647.
   PubMed Web of Science ®Google Scholar
• Shi, H., et al., 2020. Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent GSDMD-mediated cell pyroptosis. International immunopharmacology, 81, 106195. doi: 10.1016/j.intimp.2020.106195.
   PubMed Web of Science ®Google Scholar
• Singh, S.K., et al., 2016. Nanosuspension: principles, perspectives and practices. Current drug delivery, 13 (8), 1222–1246. doi: 10.2174/1567201813666160101120452.
   PubMed Web of Science ®Google Scholar
• Tian, Y., et al., 2022. Review of nanosuspension formulation and process analysis in wet media milling using microhydrodynamic model and emerging characterization methods. International journal of pharmaceutics, 623, 121862. doi: 10.1016/j.ijpharm.2022.121862.
   PubMed Web of Science ®Google Scholar
• Wang, F.D., Zhou, J., and Chen, E.Q., 2022. Molecular mechanisms and potential new therapeutic drugs for liver fibrosis. Frontiers in pharmacology, 13, 787748. doi: 10.3389/fphar.2022.787748.
   PubMedGoogle Scholar
• Wang, L., et al., 2018. Cryoprotectant choice and analyses of freeze-drying drug suspension of nanoparticles with functional stabilisers. Journal of microencapsulation, 35 (3), 241–248. doi: 10.1080/02652048.2018.1462416.
   PubMed Web of Science ®Google Scholar
• Xing, Y., et al., 2020. Nano-strategies for improving the bioavailability of inhaled pharmaceutical formulations. Mini reviews in medicinal chemistry, 20 (13), 1258–1271. doi: 10.2174/1389557520666200509235945.
   PubMed Web of Science ®Google Scholar
• Xu, G., et al., 2021. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. JCI insight, 6 (2), e134601. doi: 10.1172/jci.insight.134601.
   PubMed Web of Science ®Google Scholar
• Yu, X., et al., 2017. Preparation and characterization of mucosal adhesive and two-step drug releasing cetirizine-chitosan nanoparticle. Carbohydrate polymers, 173, 600–609. doi: 10.1016/j.carbpol.2017.05.067.
   PubMed Web of Science ®Google Scholar
• Yuan, H.L., et al., 2018. An active ingredient composition of lignan from Herpetospermum caudigerum seed and a preparation method, application and dosage form. China Patent Application CN201880081675.
   Google Scholar
• Yuan, H.L., et al., 2020. Preparation method and application of herpetetrone nanosuspension and lyophilized powder. China Patent Application CN202010144144.X.
   Google Scholar
• Zuo, J., et al., 2019. Preparation and in vitro anti-hepatic fibrosis evaluation of herpetone nanosuspensions. Zhongguo Zhong Yao Za Zhi, 44, 1164–1169.
   PubMedGoogle Scholar